Johnson & Johnson (JNJ) Cash from Operations (2009 - 2026)

Johnson & Johnson (JNJ) posted Cash from Operations of 2514000000.0 for Q1 2026, down 65.6% sequentially from 7309000000.0 in Q4 2025, and down 39.77% YoY from 4174000000.0 in Q1 2025.

Johnson & Johnson (JNJ) Cash from Operations (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Cash from Operations data on file, last reported at 2514000000.0 in Q1 2026.

  • Quarterly Cash from Operations fell 39.77% year-over-year to 2514000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 22870000000.0 (down 7.72% YoY) and the FY2025 annual result came in at 24530000000.0, up 1.09% from the prior year.
  • Cash from Operations slipped to 2514000000.0 in Q1 2026 per JNJ's latest filing, from 7309000000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 9169000000.0 in Q3 2025, with the low at 2514000000.0 in Q1 2026.
  • Average Cash from Operations over 5 years is 5439733333.33, with a median of 4182000000.0 recorded in 2023.
  • Year-over-year, Cash from Operations surged 123.63% in 2023 and plunged 39.77% in 2026.
  • Johnson & Johnson's Cash from Operations stood at 3979000000.0 in 2022, then soared by 97.61% to 7863000000.0 in 2023, then declined by 11.19% to 6983000000.0 in 2024, then gained by 4.67% to 7309000000.0 in 2025, then plunged by 65.6% to 2514000000.0 in 2026.
  • Business Quant data shows JNJ's Cash from Operations at 2514000000.0 in Q1 2026, 7309000000.0 in Q4 2025, and 9169000000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.33 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.51 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.83 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.92 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.54 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.62 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 645.50 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 2.51 Bn
Mar 29, 2026 2.51 Bn
Dec 28, 2025 7.31 Bn
Dec 28, 2025 7.31 Bn
Sep 28, 2025 9.17 Bn
Sep 28, 2025 9.17 Bn
Jun 29, 2025 3.88 Bn
Jun 29, 2025 3.88 Bn
Mar 30, 2025 4.17 Bn
Mar 30, 2025 4.17 Bn
Dec 29, 2024 6.98 Bn
Dec 29, 2024 6.98 Bn
Sep 29, 2024 7.99 Bn
Sep 29, 2024 7.99 Bn
Jun 30, 2024 5.63 Bn
Jun 30, 2024 5.63 Bn
Mar 31, 2024 3.66 Bn
Mar 31, 2024 3.66 Bn
Dec 31, 2023 7.86 Bn
Dec 31, 2023 7.86 Bn